Abstract Prostate cancer (PC) is a major health problem in adult males. TRPM8, a cationic TRP channel activated by cooling and menthol is upregulated in PC. However, the precise role of TRPM8 in PC is still unclear. Some studies hypothesized that TRPM8-mediated transmembrane Ca 2+ fluxes play a key role in cellular proliferation of PC cells. In contrast, other findings suggest that high TRPM8 levels may reduce the metastatic potential of PC cells. A detailed understanding of the response of TRPM8 channels to pharmacological modulators of their activity is relevant when considering potential therapies, targeting this ion channel to treat PC. We characterized the pharmacological and functional properties of native TRPM8 channels in four human prostate cell lines, PNT1A, LNCaP, DU145, and PC3, commonly used as experimental models of PC. PNT1A is a non-tumoral prostate cell line while the other three correspond to different stages of PC. Here, we show that cold-and agonist-evoked [Ca 2+ ] i responses in PC cells are much less sensitive to well-characterized agonists (menthol and icilin) and antagonists (BCTC, clotrimazole, and DD01050) of TRPM8 channels, compared to TRPM8 channels in other tissues, suggesting a different molecular composition and/or spatial organization. In addition, the forced overexpression of human TRPM8 facilitated the trafficking of TRPM8 channels residing in the endoplasmic reticulum to the plasma membrane, leading to a marked potentiation in the efficacy of the different blockers. These results predict that blockers of canonical TRPM8 channels may be less effective in halting proliferation of PC cells than expected.
Introduction
Prostate cancer (PC) is a major health problem, totalling one fourth of all new cancer cases diagnosed in adult males in the United States each year, and accounting for about 9% of all cancer-related death rates in the same population [1] . Recent studies have focused on the role of TRPM8, a nonselective, calcium permeable, cation channel of the transient receptor potential (TRP) melastatin subfamily of TRP channels in PC initiation and progression [reviewed by 2], making it a novel molecular target potentially useful in the diagnosis and treatment of the disease. This ion channel is activated by voltage, cold temperatures, and cooling compounds, like menthol and icilin [reviewed by 3] , and is involved in the detection of moderate cold temperatures by mammalian somatosensory nerve terminals [4, 5] .
Aside from its restricted localization in sensory neurons, the human ortholog of TRPM8, initially termed trp-p8 [6] , is also expressed in the testis, bladder urothelium, and prostate tissue [6] [7] [8] . Tsavaler and colleagues identified TRPM8 transcripts in only one human prostate cell line, the androgen-dependent LNCaP cells, of the four that were tested (PNT1A, LNCaP, DU145, PC3) [6] . In contrast, Zhang and Barritt reported a low level of expression in PC3 cells as well [9] . The expression of TRPM8 in prostate tissue and in LNCaP cells is androgen-dependent, increasing with androgen treatment and declining with anti-androgen therapy [9, 10] .
The precise physiological function of TRPM8 channels in normal and cancerous prostate tissue is still unknown. TRPM8 expression upregulates markedly in PC and in other tumors, suggesting an important role in carcinogenesis [6, 11, 12] . This upregulation is lost in the transition to androgen independence of the tumor. TRPM8 channels are calcium permeable, and altered calcium transport has been linked to cancer [reviewed by 13] , suggesting a possible connection between altered Ca 2+ levels and prostate cancer progression. Indeed, [Ca 2+ ] i elevations by TRPM8 agonists can induce proliferation of prostate cancer cells but also apoptotic cell death [reviewed by 14] but the particular role of TRPM8 in this process is still unknown. A recent study also showed effects of menthol on prostate cell viability that were TRPM8-independent, thus indicating a need to reconsider previous interpretations [15] . PC3 cells artificially overexpressing TRPM8 have reduced motility, suggesting a possible connection between TRPM8 activity and reduced metastatic potential [16] .
The subcellular localization of TRPM8 channels in prostate tissue is also controversial (see below) but clearly distinct from the membrane localization typical of a transduction ion channel such as TRPM8, a critical transducer of cold temperatures in sensory neurons. According to Thebault et al., the localization in LNCaP cells is nearly exclusive to the endoplasmic reticulum (ER) [17] . Moreover, activation of the ER channel by cold or menthol produces Ca 2+ store depletion and activates store-operated Ca 2+ currents in LNCaP cells. In contrast, the results by Zhang and Barritt suggested a dual location in the plasma membrane and the ER in about equal levels [9] . Finally, results by Mahieu et al. suggest a primarily membrane localization, attributing previous findings to non-specific labeling of commercially available antibodies [18] . Other factors influencing the subcellular localization of the channel are differentiation status of the epithelial cells, with a gradual loss of the plasma membrane localization of TRPM8 during their dedifferentiation [14, 19] . A previous study reported the presence of two different splice variants of TRPM8 in prostate cancer cells [20] . In the same line, experiments by Bidaux et al. suggest that a truncated but functional form of TRPM8 is preferentially expressed in the endoplasmic reticulum of PC3 cells [19] . However, little is known about the expression of these isoforms in different PC cells.
Recently, we performed an extensive pharmacological and functional characterization of native TRPM8 channels in neuronal tissue and following transient expression in HEK293 cells [21] [22] [23] [24] . We identified several drugs that fully blocked menthol-and cold-evoked activity of TRPM8 channels. In this work, we extended this characterization to native TRPM8 channels in a non-tumoral human prostate epithelial cell line (PNT1A) and three commonly used human prostate cancer cell lines: LNCaP, DU145, and PC3. We show that the pharmacological and functional properties of TRPM8-mediated responses differ substantially in prostate cells compared with neuronal tissue. In particular, inhibition of channel activity by current TRPM8 blockers is markedly reduced in prostate tissue. These findings may have important implications when considering possible therapeutic interventions targeting TRPM8 channels in the prostate.
Materials and methods

Culture of cell lines and transfection
All the prostate tumoral cell lines, LNCaP, DU145, PC3, and the non-tumoral cell line PNT1A were obtained from American Type Culture Collection (ATCC). HEK293 cells were obtained from the ECACC (Salisbury, UK). HEK293 and DU145 cells were cultured in DMEM with 10% fetal bovine serum (FBS). PC3, LNCaP, and PNT1A were cultured in RPMI medium supplemented with 10% FBS. Cells were grown at 37°C in a humidified atmosphere containing 5% CO 2 . All the lines were maintained without antibiotics in the media.
For transfection, cells were trypsinized and plated on poly-L-lysine-coated round coverslips (6 mm diameter) at 40,000 cells/coverslip. Cells were transiently transfected with plasmid DNA using Lipofectamine 2000 (Invitrogen), 1 μg DNA, and 5 μl Lipofectamine per milliliter. Cells were used 24-48 h post-transfection.
The human TRPM8 in pcDNA3 (a kind gift of Dr. V. Flockerzi) was co-transfected with pGreen Lantern-1 GFP (Life Technologies) at a 1:1 ratio. Transfected cells were identified by their green fluorescence emission during excitation with 470 nm light.
Neuronal culture
Trigeminal ganglion neurons from neonatal mice were cultured as described previously [25] . In brief, trigeminal ganglia were isolated from anesthetized newborn Swiss OF1 mice (P1-P5), incubated with 1 mg/ml collagenase type IA (Sigma) for 45 min at 37°C in 5% CO 2 , and cultured in medium: 45% DMEM, 45% F-12+10% FBS (Invitrogen), supplemented with 4 mM L-glutamine, 200 μg/ml streptomycin, 125 μg/ml penicillin, 17 mM glucose, nerve growth factor (mouse 7S, 100 ng/ml, Sigma). Cells were plated on poly-L-lysine-coated glass coverslips and used after 1-3 days in culture.
RNA extraction and cDNA synthesis Total RNA extraction was performed with the Micro-toMidi Total RNA Purification System (Invitrogen). The concentration and quality of the RNA was assessed by Nanodrop (Labtech International, Ringmer, UK) and agarose electrophoresis. Thereafter, equal amounts (2 μg) of total RNA was reversed transcribed using Superscript ™ II (Invitrogen) in the presence of random hexamers (Sigma) for 1 h at 50°C in a total reaction volume of 20 μl. The obtained cDNA was always used fresh to further analysis.
Quantitative real-time PCR and data analysis
Real-time quantitative PCR (RT-qPCR) was performed using the 7500 Real-Time PCR System (Applied Biosystems). Serial dilutions (2 μl) of each cDNA were amplified in a threestep cycling program with Platinum® SYBR® Green qPCR Supermix UDG (Invitrogen) and gene-specific primers in a final volume of 20 μl. We designed primer pairs specific for two splice variants of TRPM8 (Fig. 1a) . Primer sequences for the canonical TRPM8, hTRPM8, were sense: 5′-CTGTCATGGACATCCCACTG-3′ and anti-sense: 5′-CTTGGGCAAAACACACAATG-3′. Primer sequences for the splice variant hTRPM8b [26] were sense: 5′-TTCCTTCCTGTCCACACCATCG-3′ and anti-sense 5′-CAGCTCGTAAAGGATTTCCGCG-3′.
Expression levels of hTRPM8 were normalized to expression of Sn-RNP polypeptide B (GeneBank® Accession number J04564) amplified in parallel from the same cDNA samples. Primer sequences for Sn-RNP polypeptide B gene were forward: 5′-AAACAAGCAGAAAGGGAAGA-3′ and reverse: 5′-CAAGTGGAACTCGAGCAATA-3′. Finally, a dissociation curve was introduced to verify the specificity of the final products. All samples were studied in duplicate.
The primer design for hTRPM8 and Sn-RNP were performed with Primer Express software (Applied Biosystems). The ratio of the relative expression of hTRPM8 to Sn-RNP polypeptide B of each sample was calculated by using the 2 ÀΔΔCT formula.
hTRPM8 immunodetection by Western blot and immunocytochemistry
To prepare crude plasma membranes, prostate cancer cells were rinsed with PBS and lysed in hypotonic buffer A (2 mM MgCl 2 , 1 mM EDTA, 1% phenylmethylsulfonyl fluoride, 20 mM Hepes at pH 7.4). Samples were centrifuged at 9,000×g at 4°C for 10 min to obtain low-speed pellets containing the plasma membranes. Protein solubilization was achieved heating the pellets resuspended in Laemmli buffer. Equal amounts of protein were loaded and resolved by 7.5% SDS-PAGE and transferred to nitrocellulose membrane (Protran; Schleicher & Schuell). Immunodetection of hTRPM8 was performed by incubation with anti-hTRPM8 (1:500; Abcam catalog number ab3243) and anti-rabbit-HRP (1:2,000; Sigma). The ECL plus Western Blot Detection System (Amersham Pharmacia) was used to develop the signal.
For immunocytochemistry, glass coverslips with seeded cells were fixed in 4% fresh paraformaldehyde for 10 min and washed twice with PBS. After washing, cells were incubated with the membrane marker, wheat germ agglutinin (WGA) conjugated to Alexa Fluor 488, 1:200 in PBS for 10 min [27] . Cells were washed twice with PBS and permeabilized in 0.2% Triton X-100 for 10 min. After wash, cells were blocked with 3% BSA for 2 h. Primary polyclonal antihTRPM8, purified by peptide chromatography [18] , was diluted 1:1,000 in 3% BSA and incubated overnight at 4°C. The secondary antibody, Alexa Fluor 546 goat anti-rabbit, was added for 2 h at a 1:2,000 dilution. As a control, we omitted the primary antibody. In order to label the nucleus, we used DAPI. Coverslips with stained cells were mounted in a fluorescent antifading medium (Dako). Stained cells were visualized with a confocal microscope (Leica TCS SP2) equipped with 405, 488, and 543 nm laser lines. Image analysis was performed with LCS Lite software (Leica).
Temperature stimulation
Coverslips with cultured cells were placed in a microchamber and continuously perfused (∼0.8 ml/min) with solutions warmed at 34±1°C. The temperature was adjusted with a water-cooled RDTC-1 Peltier device (ReidDan Electronics) placed directly on the cell field and controlled by a feedback device [28] 
Results
Expression of TRPM8 channels in different human prostatic cell lines
We used conventional and RT-qPCR techniques to characterize the expression levels of TRPM8 mRNA in four different human prostatic cell lines. As shown in Western blots of membrane extracts prepared from hTRPM8 transfected HEK293 cells and from human prostate cancer cell lines. TRPM8 protein was detected by anti-hTRPM8 antibody and relative protein loading was determined by probing with anti-Flotillin 1 antibody. d TRPM8 mRNA expression was evaluated by quantitative RT-PCR in the four prostate cancer cell lines. Expression levels were normalized to Sn-RNP polypeptide B as described in the "Materials and methods" section. e TRPM8 splice variant (named TRPM8b) mRNA was evaluated by the same method used in d. f Quantification of TRPM8 protein expression. Band intensities from three independent experiments were quantified and normalized to Flotillin 1 expression as protein loading control. Levels were quantified relative to PNT1A expression set at 1.0 Fig. 1b , we could demonstrate the presence of hTRPM8 mRNA in the prostate cancer cell lines LNCaP, DU145, and PC3 and the non-tumoral prostate cell line PNT1A using conventional RT-PCR with specific primers for the human TRPM8 gene (Fig. 1a) . The relative expression levels of hTRPM8 mRNA in the different cell lines was further analyzed by RT-qPCR. As shown in Fig. 1d , all samples from tumoral cell lines showed an upregulated expression of hTRPM8 mRNA compared with the nontumoral prostate cell line PNT1A. A previous study [20] reported a splice variant of TRPM8 in human prostate cancer cells, differing from the canonical 1104 aa protein (here identified as TRPM8) at its amino terminus. We used a primer pair specific for this splice variant, here called TRPM8b (Fig. 1a) . Compared to PNT1A, the three PC cell lines showed an elevated expression of TRPM8b that was particularly prominent in the DU145 cell line (Fig. 1e) . The relative expression levels of canonical TRPM8 compared to TRPM8b were 9±1.6-, 6±0.8-, and 9.5± 1.8-fold higher in LNCap, DU145, and PC3 cells, respectively (n=3).
The ability to detect the expression of TRPM8 mRNA in the four cell lines prompted us to investigate the expression of TRPM8 protein. To address this issue, we prepared membrane fractions of the four cell lines. As shown in Fig. 1c , the expression of TRPM8 protein was confirmed in crude membrane extracts for the three cancerous cell lines by Western blot, appearing as a 128-kDa band, while expression in PNT1A was very faint. In the same preparations, as control of relative protein loading, we immunodetected Flotillin-1, a membrane-bound protein that colocalizes with TRPM8 within lipid rafts [31] . HEK293 cells transfected with human TRPM8 cDNA also gave rise to a strong band of the same size, which was absent in wildtype (i.e., untransfected) HEK293 cells, confirming the specificity of the antibody (Fig. 1c) . A quantification of relative TRPM8 protein expression for the four cell lines is shown in Fig. 1f .
Next, we used confocal microscopy to define the cellular localization of the TRPM8 protein in the four prostate cell lines [18] . The plasma membrane was co-stained with the Alexa Fluor 488 conjugate of the lectin WGA, and the nucleus was stained with DAPI. As illustrated in a typical example of a DU145 cell ( Supplementary Fig. 1A-D) , the bulk of the TRPM8 signal appeared localized in the cytosol in a reticulate pattern. Most of the TRPM8 label spared the nuclear region. Similar results were obtained for LNcaP ( Supplementary Fig. 1E ) and PC3 cells ( Supplementary  Fig. 1F ). In PNT1A cells, TRPM8 inmunostaining was weak or absent (not shown).
These experiments established the expression of TRPM8 protein in the three human cancer prostate cell lines. The results confirm previous observations of other laboratories for LNCaP [9, 18, 19] and PC3 [9] cells and provide novel information about expression of TRPM8 in DU145. The expression of TRPM8 protein in the non-tumoral PNT1A cell line was clearly lower than in the cancer lines, an observation in line with the known upregulation of TRPM8 in prostate cancer [6] . ] i response (Fig. 2b) . In the rest, the response was labile and disappeared during the second stimulus (not shown). ] i response was also larger in LNCaP compared to PC3 and DU145, and this difference was significant (Fig. 2d) . The [Ca 2+ ] i responses to the temperature drop developed slowly during cooling (Fig. 2e ). For comparison, we applied identical cooling protocols to HEK293 cells transfected with hTRPM8 (Fig. 2f) . Cold-evoked responses were more frequent (Fig. 2c) , had a much larger amplitude (Fig. 2d) , and had a faster rise time (Fig. 2g) ] i signals in responsive cells were quite stable in amplitude and time course. On average, the amplitude of the second and third response were only 9% and 35% smaller than the first one (n=30, p<0.001, ANOVA). This relative stability of the cold-evoked responses greatly facilitated the analysis of the pharmacological interventions that we performed.
Responses to menthol and icilin
In contrast to thermal responses, the effects of menthol and icilin, two chemical agonists of TRPM8 channels [4, 32] were much less reproducible in prostate cancer cells compared to results obtained in sensory neurons [21] or TRPM8-transfected cells [22] . Very few cells responded to 500 μM menthol applied at 35°C (Supplementary Fig. 3A) . Similarly, few cells responded to the ultrapotent agonist icilin (10 μM; not shown). However, cold-evoked responses were slightly potentiated by the co-application of menthol ( Supplementary Fig. 3A) or icilin (not shown). A summary of these results for the different PC cells is shown in Supplementary Fig. 3b .
Effect of Ca
2+ store depletion on responses to TRPM8 agonists in human prostatic cell lines There is some debate regarding the subcellular localization of TRPM8 channels in different PC cells lines [9, 10, 17] and on the ability of chemical agonists to activate these channels. Some studies suggest the exclusive presence of TRPM8 channels within the ER while others indicate a dual presence at the plasma membrane and within the ER [9] . lines (Fig. 3b-d) ] i elevation observed in the response to cooling. Second, to assess the contribution of the ER to the cold-evoked Ca 2+ response more directly, we performed experiments after ER Ca 2+ store depletion. To this end, cells were stimulated with a cooling ramp in control solution and after blockade of SERCA pumps with BHQ (10 μM) applied to the bath. As shown in Fig. 3e , shortly after BHQ application, the [Ca 2+ ] i rose steadily in the LNCaP and DU145, the two PC cell lines tested, a situation that made comparison with control conditions complicated. Nevertheless, ∼75% of LNCaP cells and ∼50% of DU145 cells still responded to the second cold stimulus. For comparison, nearly all (98%) of HEK293 transfected with hTRPM8 gave rise to a robust cold-evoked response after store depletion with BHQ (Fig. 3e) , suggesting a primarily location of TRPM8 at the plasma membrane. Altogether, these results suggest a dual component of the [Ca 2+ ] i elevation in response to agonists in PC cells, a major fraction flowing through the plasma membrane and a smaller component due to Ca 2+ mobilization from stores.
During the course of the study, we also noticed that the plasma membrane of PC cells was extremely leaky to calcium ions compared to other cells (e.g., HEK293 cells). Previous studies in LNCaP cells ascribed this elevated permeability to the elevated expression of TRPV6, a highly Ca 2+ selective TRP channel [33] . The relative leakiness of the plasma membrane to Ca 2+ was quantified in LNCaP, PNT1A and untransfected HEK293 cells, in experiments where the external Ca 2+ was stepped from normal (2.4 mM) to low (0 Ca 2+ ), back to normal, and finally to high (10 mM) Ca 2+ levels. As shown in Fig. 4a 2+ stores can also increase the permeability of the plasma membrane to calcium [34] . To further test the influence of empty calcium-store conditions on the permeability of the plasma Fig ] i levels (∼20 nM; Fig. 4e ), and these changes remained modest (∼50 nM) even after incubation in TG (Fig. 4c and e) ] i that reflect the higher basal permeability described previously. The same experiment performed after incubation in TG produced a dramatic oscillation in the [Ca 2+ ] i . This result is exemplified in Fig. 4d for DU145 cells, but similar results were obtained for all the PC cell lines (Fig. 4f-h) .
Altogether, these results suggest that PC cells have an elevated transmembrane permeability to calcium, even under basal conditions. Thus, rapid leakage of stored calcium may underestimate the fraction of the response to cooling that originates in the stores.
Effects of overexpression of hTRPM8 on cold-and agonistevoked [Ca 2+ ] i signals in human prostatic cell lines
Transfection of TRPM8 in PC3 cells induced a prominent outwardly rectifying menthol-activated current, typical of membrane-bound TRPM8 channels, that was completely absent in wild-type (i.e., untransfected) PC3 cells [19] . In contrast, TRPM8 channels overexpressed in LNCaP cells appear to be retained in the endoplasmic reticulum [17] . Thus, we decided to investigate, in a systematic fashion, the responses of the three PC cell lines to cooling, menthol and icilin, after transfection with hTRPM8. Cells transfected with hTRPM8 were identified by the co-transfection with GFP (Fig. 5a , see "Materials and methods" section). The basic protocol is shown in Fig. 5b , with DU145 cells in this particular example, and consisted of applications of menthol (500 μM) and icilin (10 μM) at 35°C, followed by a pulse of cold temperature to ∼20°C. Typically, GFP(+) cells (red traces) gave rise to large amplitude [Ca 2+ ] i responses to the three stimuli ( Fig. 5c and Supplementary Table 1 ). The probability that a GFP(+) cell responded to the three stimuli was >69%, and the majority of the remaining cells were unresponsive to any of the three stimuli, suggesting that the efficiency of co-transfection of hTRPM8 and GFP was not 100%. In contrast, the large majority of GFP(−) cells did not respond to the three agonists (not shown).
An unexpected result was obtained when the cold stimulus was applied in the absence of external Ca 2+ to measure the fraction of response dependent on release from intracellular calcium stores. Under these conditions, the [Ca 2+ ] i elevation produced by cooling was systematically larger for untransfected cells (black traces) compared to hTRPM8-transfected cells (red traces), although the amplitude of the [Ca 2+ ] i signal was generally less than 10% of that measured in control (2.4 mM) external Ca 2+ (Fig. 5d) . As a matter of fact, the response evoked from stores was virtually absent in all PC cell lines cells overexpressing hTRPM8 (Fig. 5e-g ).
These experiments suggest that overexpression of hTRPM8 produces two important effects. [9, 19] and the pharmacological manipulation of TRPM8 activity could be a key target in modulating the growth of PC cells. Thus, we decided to explore the effects of a novel and two previously characterized TRPM8 blockers on calcium signals in the three PC cells.
BCTC is a potent blocker of cold-and menthol-evoked responses on neuronal and recombinant TRPM8 channels [21] [22] [23] 32] . As shown in Fig. 6a, 10 (Fig. 6b) . The mean results for untransfected and transfected LNCaP cells are shown in Fig. 6c and d, respectively . Intriguingly, the amplitude of the residual [Ca 2+ ] i signal in BCTC was nearly identical in both cases. As summarized in Fig. 6e and Table 1 , blockade of cold-evoked responses by BCTC was clearly less effective in native (i.e., untransfected) PC cells (black bars) compared with TRPM8-transfected cells (gray bars).
We performed similar studies with two other blockers of TRPM8 channels, clotrimazole [23, 24] and DD01050, on the three PC cells lines. Clotrimazole is particularly interesting because of its dual effects on TRP channel activity; it activates TRPA1 and TRPV1 but blocks TRPM8 [24] . The results were comparable to those obtained with BCTC. As shown in Fig. 6f , the inhibition of cold-evoked responses with clotrimazole was always significantly higher in PC cells co-transfected with hTRPM8.
DD01050 is a novel, orally bioactive, TRP channel blocker [35] . In addition to its blocking effect on TRPV1, we also found a potent blocking effect of DD01050 on cold-evoked responses of mouse trigeminal neurons and of human TRPM8 channels expressed in HEK293 cells (Fig. 7a-c) . In contrast, as was the case with the two other TRPM8 blockers tested (i.e., BCTC and clotrimazole), the inhibition was much less effective on cold-evoked responses in wild-type PC cells (Fig. 7d) , and this inhibition was strongly potentiated on PC cells cotransfected with hTRPM8 (Fig. 7e) . A summary of the differential inhibition of cold-evoked responses by DD01050 in different native and hTRPM8-transfected PC cells is shown in Fig. 7f .
Altogether, these results indicate that native cold-evoked responses in PC cells have a lower sensitivity to blockers of TRPM8 channels compared to responses observed in sensory neurons or in the same cells transfected with TRPM8, strongly suggesting a different molecular composition and/or subcellular localization of these channels in native PC cells.
To explore this question further, we asked whether endogenous cold-evoked responses in the absence of external Ca 2+ (see Fig. 3a ) had different pharmacological properties to TRPM8 blockade, compared to responses in control (i.e., 2.4 mM Ca 2+ ). As shown in Supplementary  Fig. 4 , the amplitude of cold-evoked responses in zero Ca 2+ was nearly identical in the absence or presence of 10 μM BCTC. This result indicates that TRPM8 channels located in the endoplasmic reticulum are almost insensitive to BCTC applied extracellularly.
Discussion
There is a pressing need for novel therapeutic strategies in the treatment of metastatic prostate cancer. In this context, the ion channel TRPM8 has emerged as a promising new therapeutic target and biomarker of different stages of this disease [2, 36, 37] . The most important finding in our study is the discovery that TRPM8-mediated Ca 2+ responses, including kinetic properties and the sensitivity to drugs, are distinct in prostate cancer epithelial cells when compared to canonical responses of TRPM8 in transfected cells or in sensory neural tissue. Furthermore, responses of hTRPM8 channels overexpressed in prostate cells are also different from those observed for the native channels in the same cells. These clear differences may be explained by a different molecular composition and/or localization of the functional channels and have important implications for the design of successful therapeutic strategies that target TRPM8.
Expression of TRPM8 in different prostate cells
Using different biochemical and molecular techniques, we could demonstrate the presence of TRPM8 in four different prostate epithelial cell lines: PNT1A, LNCaP, DU145, and PC3. The most striking difference between the four lines, especially at the functional level, was the reduced activity of TRPM8 in the non-tumorous cell line PNT1A compared with the three PC cell lines. These results generally agree with the pioneering work of Tsavaler et al., demonstrating overexpression of TRPM8 in malign prostate cancer cells [6] . Of the PC cell lines probed with TRPM8 agonists, responses in LNCaP were most robust, correlating with the higher expression of the classical isoform. This result agrees with previous studies that always observed TRPM8-mediated responses in this cell line. The higher functional expression of TRPM8 in LNCaP cells is consistent with the following facts. First, TRPM8 expression is regulated by androgens, and this cell line is the only one of the three PC cells lines that expresses the androgen receptor [9, 10] . Second, androgens promote the expression of classical TRPM8 at the plasma membrane [19] . Albeit smaller, functional responses in DU145 and PC3 were also clear. In contrast, functional responses in the non-tumorous cell line PNT1A were very rare, despite detection of the protein, albeit at lower levels.
Of the different anti-TRPM8 antibodies we tested (information available upon request), only the noncommercial antibody used by Mahieu et al. [18] provided a reliable staining detectable by immunofluorescence. Staining was mostly located within cytoplasmic granules. However, both the density profiles and the functional responses indicate the presence of TRPM8 at the plasma membrane. Detection of other molecular markers in different PC cell lines, including the widely used androgen receptor, has also been subject to controversy [17, 38] . The variability in the ability to detect this key protein in prostate cells has been ascribed to methodological questions and variable expression levels, a factor that could also influence TRPM8 detection.
Regardless of the sensitivity of the different methods employed, we feel that the functional responses to cold and chemical agonists (menthol and icilin) that we observed and the reversible inhibition of these responses by all the classical TRPM8 blockers tested provided unambiguous evidence for expression of functional TRPM8 channels in the three PC cell lines. The limited functional response in PNT1A cells speaks in favor of a much lower expression level, a result also supported by the quantitative RT-PCR and protein expression results. Functional Ca 2+ responses in the three PC cell lines were caused primarily, but not exclusively, by enhanced influx through the plasma membrane, a result that fully agrees with the observations by Zhang and Barritt in LNCaP cells [9] .
Another clear result was the variability in the response to cold and chemical agonists in individual prostate cells. Phenotypic variation in cell lines is a troublesome but wellrecognized phenomenon, also in prostate cell lines [39] , with several underlying mechanisms driving this variability: genetic instability, epigenetic silencing by DNA hypermethylation, and post-transcriptional modifications. It is not clear whether the changes in TRPM8 responses that we observed reflect stable differences in protein levels or longer time scale fluctuations [40] . It is worth mentioning that dedifferentiation of prostate epithelial cells in culture leads to major changes in TRPM8 function [19] .
Characteristics of TRPM8-evoked responses in prostate cancer cells
As indicated, we found major differences in the prevalence, kinetics, amplitude, and pharmacological profiles of coldevoked [Ca 2+ ] i responses in PC cells in comparison with canonical or classical TRPM8-mediated responses observed in recombinant systems (e.g., HEK293 cells) and mammalian cold-sensitive neurons [4, 5, 21, 41, 42] . In LNCaP cells, the membrane current activated by cold and/or menthol have also very different biophysical properties compared to the typical TRPM8-mediated currents [17] . Physical (i.e., temperature) or chemical (i.e., menthol and icilin) activators of TRPM8 are less effective on prostate cells compared with neural tissue. In addition, drugs that inhibit classical TRPM8 function also inhibit, albeit less effectively, cold-evoked response in prostate cells. Moreover, the responses in the absence of external Ca 2+ , presumably from channels located in the ER, were nearly insensitive to the TRPM8 blocker BCTC. These results suggest that the lack of accessibility of the drugs to a fraction of the channels (i.e., those located intracellularly) may explain the lower overall sensitivity to blockade observed in prostate cancer cells. However, it should be pointed out that the differential pharmacology may reflect a different molecular composition, which leads to intracellular retention of those channels. These two hypotheses for explaining the differential pharmacology of prostate TRPM8 channels are not mutually exclusive. It is intriguing that the ratios of canonical TRPM8 to the TRPM8b isoform in PC cells are roughly similar to the ratios of response amplitudes in the presence or absence of external Ca 2+ . Recently, Bidaux et al. [19] provided convincing evidence that the functional and molecular properties or TRPM8 channels located in the ER are distinct from those at the plasma membrane.
Role of TRPM8 channels in prostate cells
The role of TRPM8 in the physiology of the prostate and the pathophysiology of prostate cancer is still unclear. In 43] . Furthermore, the complement of ion channels and the activity of calcium entry pathways are different in prostate cancer cell lines with different metastatic potential [44] . Besides TRPM8, several TRP channels have been detected in PC cancer cells, including TRPC1, TRPC4, TRPC6, and TRPV6 [45] [46] [47] Due to its dual localization in the plasma membrane and the ER, activation of TRPM8 channels will allow calcium entry and release from stores, modulating different pools of intracellular Ca 2+ . This Ca 2+ homeostasis is important in many cellular processes including gene transcription, cellular differentiation, proliferation, and apoptosis [43, 48, 49] 43, 54] , also in PC cells [48] . Thapsigargin treatment, and subsequent Ca 2+ -store depletion, triggered the activation of a calcium influx pathway in prostate cells. This activation was prominent in all tumoral cells lines in comparison with the non-tumoral cell line. A similar pathway has been recently described in LNCaP cells [55] . 
Therapeutical implications of TRPM8 expression in PC cells
Interest in development of novel therapeutic agents against prostate cancer is currently very high; over 200 compounds have entered clinical development for use in the treatment of advanced prostate cancer [56] . The selective overexpression of TRPM8 in prostate cancer cells [6] made this channel a promising novel target. However, as already mentioned, it is still unclear whether increasing or decreasing TRPM8 function is the proper strategy for inhibiting the growth of PC cells. Inhibition of TRPM8 expression leads to reduced proliferation of PC cells [2] . On the other hand, activation of Ca 2+ influx pathways has been shown to induce apoptosis in LNCaP cells [51] . Thus, activators of TRPM8 channels may find a clinical application. We see three major implications of our findings for the development of future therapies targeting TRPM8. (1) Nonpermeable drugs against TRPM8, such as humanized functional antibodies, may not be as effective in blocking the activity of the channel as predicted based on studies in recombinant systems. A fraction of native TRPM8 channels in prostate tissue are located intracellularly and appear less accessible to drugs that are effective agonists or antagonists of canonical TRPM8 function [22, 32] . In contrast, silencing of endogenous TRPM8 mRNA (e.g., with antisense or specific siRNA) would not suffer from these limitations and has already been shown to be effective in halting proliferation of prostate cancer cells [9] . (2) Overexpressing TRPM8 facilitates translocation of endogenous TRPM8 from intracellular compartments to the plasma membrane, making the channels more accessible to pharmacological modulation. Thus, an alternative treatment strategy could be based on the activation of trafficking towards the plasma membrane by pharmacological intervention. For example, application of epidermal growth factors can produce the rapid translocation of TRPC5 channels to the plasma membrane [57] . Also, activation of PKC can produce a rapid delivery of functional TRPV1 channels to the plasma membrane [58] . (3) The design of non-functional channel subunits as an alternative mechanism to alter the functional activity of TRPM8 should be considered as a therapeutic alternative.
Finally, in order to calibrate the true clinical relevance of our findings, future studies should try to verify them on acutely isolated epithelial prostate cancer cells. Although our results were qualitatively very similar in the three cancerous cell lines tested, this may not be the case in intact tissue.
